Therapeutic potential of medicinal marijuana: an educational primer for health care professionals

This review is particularly important for primary care physicians whose patients may be interested in using as an alternative therapy. In response to increased interest in medicinal marijuana (MM), Health Canada released a document in 2013 for general practitioners (GPs) as an educational tool on the efficacy of MM in treating some chronic and acute conditions. The purpose of this paper is to offer physicians an educational tool that provides a necessary, evidence-based analysis of the therapeutic potential of MM and to ensure physicians are making decisions on the therapeutic use of MM in good faith.

Short-Term Efficacy of CBD-Enriched Hemp Oil in Girls with Dysautonomic Syndrome after Human Papillomavirus Vaccination

Cannabidiol (CBD)-based treatments for several diseases, including Tourette’s syndrome, multiple sclerosis, epilepsy, movement disorders and glaucoma, are proving to be beneficial and the scientific clinical background of the drug is continuously evolving. This study demonstrated the safety and tolerability of CBD-rich hemp oil and the primary efficacy endpoint. Randomized controlled trials are warranted to characterize the safety profile and efficacy of this compound.

New Jersey Medical Marijuana Panel Approves 5 New Qualifying Conditions

Anxiety and migraine sufferers may get a chance to use medical cannabis as a treatment in the Garden State New Jersey’s notoriously strict medical marijuana program may be on the road to expansion, thanks to the approval of five new ailments as qualifying conditions for medical cannabis by state regulators. Patch reports that the state’s Medicinal Marijuana Review Panel…